Ocrelizumab in pediatric patients with MS: Efficacy, tolerability, and safety

被引:0
|
作者
Zeydan, Burcu [1 ]
机构
[1] Mayo Clin, Dept Neurol & Radiol, Rochester, MN 85054 USA
关键词
D O I
10.1016/j.ejpn.2023.03.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A1 / A1
页数:1
相关论文
共 50 条
  • [41] Safety and Efficacy of Ocrelizumab in Patients who Transitioned Directly from Alemtuzumab Therapy
    Miller, Paul
    Tran, Vince
    Jarrar, Rawan
    Fast, Jonas
    Olson, Jill
    Miller, Tamara
    Miravalle, Augusto
    NEUROLOGY, 2020, 94 (15)
  • [42] Safety and tolerability of cidofovir in high-risk pediatric patients
    Bhadri, V. A.
    Lee-Horn, L.
    Shaw, P. J.
    TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (04) : 373 - 379
  • [43] Efficacy and tolerability of adjunctive lacosamide in pediatric patients with focal seizures
    Farkas, Viktor
    Steinborn, Barbara
    Flamini, J. Robert
    Zhang, Ying
    Yuen, Nancy
    Borghs, Simon
    Bozorg, Ali
    Daniels, Tony
    Martin, Paul
    Carney, Hannah C.
    Dimova, Svetlana
    Scheffer, Ingrid E.
    NEUROLOGY, 2019, 93 (12) : E1212 - E1226
  • [44] Clinical Efficacy and Tolerability of Linezolid in Pediatric Patients: A Systematic Review
    Chiappini, Elena
    Conti, Camilla
    Galli, Luisa
    de Martino, Maurizio
    CLINICAL THERAPEUTICS, 2010, 32 (01) : 66 - 88
  • [45] Safety, Tolerability, Efficacy & Dosing of Rufinamide in Pediatric Epilepsy: A Single Center Experience
    Gooty, Vasu
    Loddenkemper, Tobias
    Vendrame, Martina
    Takeoka, Masanori
    Bergin, Ann
    Eksioglu, Yaman
    Duffy, Frank
    Rotenberg, Alexander
    Poduri, Annapurna
    Libenson, Mark
    Bourgeois, Blaise
    Kothare, Sanjeev
    NEUROLOGY, 2010, 74 (09) : A304 - A304
  • [46] Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and Tolerability
    Eric T. Dobson
    Jeffrey R. Strawn
    Pediatric Drugs, 2016, 18 : 45 - 53
  • [47] Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and Tolerability
    Dobson, Eric T.
    Strawn, Jeffrey R.
    PEDIATRIC DRUGS, 2016, 18 (01) : 45 - 53
  • [48] An open-label study of ziprasidone in pediatric patients with bipolar disorder: Safety, tolerability, efficacy, and functional outcomes
    DelBello, Melissa
    Versavel, Mark
    Ice, Kathleen
    Keller, David
    Stewart, Michelle
    Miceli, Jeffrey
    BIPOLAR DISORDERS, 2006, 8 : 27 - 27
  • [49] Safety, efficacy, and tolerability of alemtuzumab in pediatric patients with active relapsing-remitting multiple sclerosis: The LemKids study
    Chitnis, Tanuja
    Arnold, Douglas L.
    Quartier, Pierre
    Chirieac, Magdalena
    Hu, Wenruo
    Jurgensen, Stephanie
    Havrdova, Eva K.
    MULTIPLE SCLEROSIS JOURNAL, 2025, 31 (01) : 23 - 35
  • [50] Long-term safety, efficacy, and tolerability of levetiracetam in pediatric patients with epilepsy in Uygur, China: A retrospective analysis
    Zhao, Ting
    Li, Hong-jian
    Yu, Jing
    Wang, Ting-ting
    Feng, Jie
    Ma, Long
    Sun, Li
    Sun, Yan
    Yu, Lu-hai
    EPILEPSY & BEHAVIOR, 2021, 120